Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Wagner, W; Bork, S; Lepperdinger, G; Joussen, S; Ma, N; Strunk, D; Koch, C.
How to track cellular aging of mesenchymal stromal cells?
AGING-US. 2010; 2(4): 224-230. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText

 

Autor/innen der Med Uni Graz:
Strunk Dirk
Altmetrics:

Dimensions Citations:

Plum Analytics:
Number of Figures: 2
| |
Abstract:
Mesenchymal stromal cells (MSC) are currently tested in a large number of clinical trials and raise high hope in regenerative medicine. These cells have to be expanded in vitro before transplantation and several studies demonstrated that long-term culture evokes continuous changes in MSC: proliferation rate decays, the cell size increases, differentiation potential is affected, chromosomal instabilities may arise and molecular changes are acquired. Long-term culture of cell preparations might also have therapeutic consequences, although this has hardly been addressed in ongoing trials so far. Reliable therapeutic regimens necessitate quality control of cellular products. This research perspective summarizes available methods to track cellular aging of MSC. We have demonstrated that gene expression changes and epigenetic modifications are continuously acquired during replicative senescence. Molecular analysis of a suitable panel of genes might provide a robust tool to assess efficiency and safety of long-term expansion.
Find related publications in this database (using NLM MeSH Indexing)
Cell Aging -
Chromosome Aberrations -
Humans -
Mesenchymal Stem Cell Transplantation -
Mesenchymal Stem Cells - cytology
Stromal Cells - cytology
Telomere -

Find related publications in this database (Keywords)
mesenchymal stem cells
replicative senescence
long-term culture
senescence marker
gene expression
© Meduni Graz Impressum